Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Mar-24
- 18-Apr-24
- 09-May-24
Select bar for recommendation details.
Recommendations | 09-May-24 | |
---|---|---|
Buy | 0 | |
Outperform | 0 | |
Hold | 1 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast
The 2 analysts offering 12 month price targets for Shield Therapeutics PLC have a median target of 26.00, with a high estimate of 50.00 and a low estimate of 2.00. The median estimate represents a 1,200.00% increase from the last price of 2.00.
High | 2,400.0% | 50.00 |
Med | 1,200.0% | 26.00 |
Low | 0.0% | 2.00 |
Earnings history & estimates
Average growth rate | -59.12% |
More ▼
Revenue history & estimates
Average growth rate | +397.24% |
More ▼